Title : Sunitinib malate inhibits intestinal tumor development in male ApcMin/+ mice by down-regulating inflammation-related factors with suppressing β-cateinin/c-Myc pathway and re-balancing Bcl-6 and Caspase-3.

Pub. Date : 2021 Jan

PMID : 33191180






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Sunitinib malate inhibits intestinal tumor development in male ApcMin/+ mice by down-regulating inflammation-related factors with suppressing beta-cateinin/c-Myc pathway and re-balancing Bcl-6 and Caspase-3. Sunitinib B cell leukemia/lymphoma 6 Mus musculus
2 These results suggest that sunitinib malate can significantly improve the survival status and inhibit intestinal tumor development in male ApcMin/+ mice, through inhibiting inflammation-related factors, while suppressing beta-cateinin/c-Myc pathway and re-balancing protein levels of Bcl-6 and Caspase-3. Sunitinib B cell leukemia/lymphoma 6 Mus musculus